Original Articles

Clinical and Laboratory Predictors of COVID-19 Severity: Identifying Key Biomarkers for Risk Stratification and Patient Outcomes

Abstract

Identifying clinical and laboratory markers associated with COVID-19 severity can aid in risk stratification and management. This study investigates the correlation between demographic, clinical, and laboratory parameters with disease severity and patient outcomes. This study encompassed all COVID-19 patients admitted to hospitals in Thi-Qar, Iraq, from January 2020 to February 2022. A total of 148 COVID-19 patients were evaluated. Two skilled chest radiologists separately examined all Computed Tomography (CT) scans. Key variables, including age, diastolic blood pressure, respiratory rate, Oxygen saturation (O₂ Sat), white blood cell count (WBC), blood urea nitrogen (BUN), potassium (K), albumin (Alb), creatine phosphokinase (CPK), C-reactive protein (CRP), and lactate dehydrogenase (LDH). Data analysis was conducted using SPSS version 23. The variables of age, diastolic blood pressure, respiratory rate, O₂ Sat, WBC, BUN, K, Alb, CPK, CRP, and LDH were significantly associated with the severity of the disease. The results found strong correlations between clinical and laboratory variables and CT severity scores, with oxygen saturation demonstrating a negative correlation with CT severity in both discharged (-0.41, P<0.001) and expired (-0.344, P=0.003) patients. WBC and absolute neutrophil count (ANC) were positively correlated with CT severity in both patient groups, while LDH and CRP exhibited strong positive correlations with CT severity in both discharged and expired patients. Additionally, serum albumin showed a negative correlation with CT severity in discharged patients, and potassium had a positive correlation in the discharged group. In expired patients, total bilirubin exhibited a negative correlation with CT severity. Comorbidities such as ischemic heart disease and cancer also significantly influenced patient outcomes. Our study identifies the significant role of clinical and laboratory parameters in predicting COVID-19 severity, highlighting the importance of early detection and intervention.

1. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. Int J Epidemiol 2020;49:717-26.
2. Zeyaullah M, AlShahrani AM, Muzammil K, Ahmad I, Alam S, Khan WH, et al. COVID-19 and SARS-CoV-2 variants: current challenges and health concern. Front Gen 2021;12:693916.
3. da Silva SJ, Silva CT, Guarines KM, Mendes RP, Pardee K, Kohl A, Pena L. Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infectious Dis 2020;6:2319-36.
4. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, et al. Diagnosing COVID-19: the disease and tools for detection. ACS nano 2020;14:3822-35.
5. Baro B, Rodo P, Ouchi D, Bordoy AE, Amaro EN, Salsench SV, et al. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. J Infect Res 2021;82:269-75.
6. Bustin S, Mueller R, Shipley G, Nolan T. Covid-19 and diagnostic testing for SARS-CoV-2 by RT-qPCR—facts and fallacies. Int J Mol Sci 2021;22:2459.
7. Park JH, Jang W, Kim SW, Lee J, Lim YS, Cho CG, et al. The clinical manifestations and chest computed tomography findings of coronavirus disease 2019 (COVID-19) patients in China: a proportion meta-analysis. Clin Exp Otorhinolaryngol 2020;13:95-105.
8. Sánchez-Oro R, Nuez JT, Martínez-Sanz G. Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19). Medicina Clínica (English Edition) 2020;155:36-40.
9. Aguadero IS, Casajús AE, Ferradas FM, Rouilleault AI, Nuin AP, Villoslada JP, et al. Chest computed tomography findings in different phases of SARS-CoV-2 infection. Radiología (English Edition) 2021;63:218-27.
10. Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, et al. Diagnostics for SARS-CoV-2 infections. Nat Mater 2021;20:593-605.
11. Cozzi D, Cavigli E, Moroni C, Smorchkova O, Zantonelli G, Pradella S, Miele V. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 2021;39:721-32.
12. Chen HJ, Qiu J, Wu B, Huang T, Gao Y, Wang ZP, et al. Early chest CT features of patients with 2019 novel coronavirus (COVID-19) pneumonia: relationship to diagnosis and prognosis. Eur Radiol 2020;30:6178-85.
13. Stojanovic Z, Gonçalves-Carvalho F, Marín A, Capa JA, Domínguez J, Latorre I, et al. Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19–changing paradigms?. ERJ Open Res 2022;8.
14. Jayachandran AK, Nelson V, Shajahan ME. Chest CT severity score as a predictor of mortality and short-term prognosis in COVID-19. J Family Med Prim Care 2022;11:4363-7.
15. Feng Z, Yu Q, Yao S, Luo L, Zhou W, Mao X, Li J, Duan J, Yan Z, Yang M, Tan H. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics. Nat Commun 2020;11:4968.
16. Ghayda RA, Lee J, Lee JY, Kim DK, Lee KH, Hong SH, Han YJ, Kim JS, Yang JW, Kronbichler A, Smith L. Correlations of clinical and laboratory characteristics of COVID-19: a systematic review and meta-analysis. Int J Environ Res Public Health 2020;17:5026.
17. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med 2020;26:506-10.
18. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
19. Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, et al. Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY) 2020;12:15670.
20. Banoei MM, Dinparastisaleh R, Zadeh AV, Mirsaeidi M. Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying. Crit Care 2021;25:1-4.
21. Tjendra Y, Al Mana AF, Espejo AP, Akgun Y, Millan NC, Gomez-Fernandez C, et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med 2020;144:1465-74.
22. Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, et al. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci2020;63:1678-87.
23. Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol 2020;55:332-9.
24. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT Findings in Patients with Coronavirus Disease 2019 and Its Relationship With Clinical Features. Invest Radiol 2020;55:257-61.
25. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020;296: 32-40.
26. Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology 2020;296: 145- 55.
27. Li B, Li X, Wang Y, Han Y, Wang Y, Wang C, et al. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019. Emerg Microbes Infect 2020;9:787-93.
28. Liu Z, Jin C, Wu CC, Liang T, Zhao H, Wang Y, et al. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia. Korean J Radiol 2020;21:736-45.
29. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect 2020;80:656-65.
30. Pugliese L, Sbordone FP, Grimaldi F, Ricci F, F DIT, Spiritigliozzi L, et al. Chest Computed Tomography Scoring in Patients with Novel Coronavirus-infected Pneumonia: Correlation with Clinical and Laboratory Features and Disease Outcome. In Vivo 2020;34:3735-46.
31. Xu Z, Zhang Y, Zhang C, Xiong F, Zhang J, Xiong J. Clinical features and outcomes of COVID-19 patients with acute kidney injury and acute kidney injury on chronic kidney disease. Aging Dis 2022;13:884-98.
Files
IssueVol 63 No 2 (2025) QRcode
SectionOriginal Articles
DOI https://doi.org/10.18502/acta.v63i2.18969
Keywords
COVID-19 Computed tomography Laboratory parameter Prognosis
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Aal-Mawlah YH, Hashim Shaheed S, Hussein Jaasim K, Sajid Abdulabbas H, Ibrahim HF. Clinical and Laboratory Predictors of COVID-19 Severity: Identifying Key Biomarkers for Risk Stratification and Patient Outcomes. Acta Med Iran. 2025;63(2):134-142.